This fall, drugs from the New England Compounding Center in Framingham, Mass., were linked to more than 700 illnesses and 46 deaths due to meningitis. The company and its sister company Ameridose in Westborough, Mass., closed in October, worsening already existing drug shortages at hospitals in the state.
On Feb. 13, Massachusetts’ Public Health Council approved regulations giving the state health commissioner long-term approval for certain hospitals to receive compounded medications from larger hospitals to ease this shortage, according to the report. These new regulations expand emergency rules approved in November that allowed temporary waivers to restrictions against hospitals sharing medications.
More Articles on the Fungal Meningitis Outbreak:
Hospitals Can Share Drugs to Ease Shortage Under New Massachusetts Regulations
Senate Committee Faults “Bureaucratic Inertia” in Meningitis Outbreak
FDA: Avoid Meningitis Contamination, Discontinue Use of New England Compounding Center Products
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.